Home › Funds › Claret Asset Management Corp › INDV
Claret Asset Management Corp position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Claret Asset Management Corp reported holding 677,878 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$24.3M, representing 2.57% of its reported portfolio and ranking #12 among its reported holdings. Claret Asset Management Corp has disclosed INDV holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Claret Asset Management Corp's INDV position evolved
Claret Asset Management Corp first disclosed a stake in INDV in Q4 2024 at 748,486 shares (US$9.3M). The position peaked in Q2 2026 at 685,523 shares, worth US$28.1M. Across 7 filings, Claret Asset Management Corp increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 677,878 shares valued at US$24.3M — a reduction of -7,645 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 748.49K | $9.30M | New |
| Q1 2025 | 745.22K | $7.10M | Hold |
| Q2 2025 | 744.28K | $10.97M | Hold |
| Q3 2025 | 784.59K | $18.92M | Add |
| Q1 2026 | 707.27K | $21.56M | New |
| Q2 2026 | 685.52K | $28.13M | Reduce |
| Q3 2026 | 677.88K | $24.30M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$173.9M), Two Seas Capital LP (US$131.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Madison Avenue Partners, LP 4.85M sh · $173.94M · Q3 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- GENDELL JEFFREY L 1.15M sh · $41.10M · Q3 2026
- MANGROVE PARTNERS IM, LLC 1.13M sh · $40.68M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 945.55K sh · $33.90M · Q3 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- PFM Health Sciences, LP 741.86K sh · $26.60M · Q3 2026
More on Claret Asset Management Corp
FAQ
How long has Claret Asset Management Corp held INDV?
Claret Asset Management Corp has disclosed INDV holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Claret Asset Management Corp's current position in INDV?
As of Q3 2026, Claret Asset Management Corp holds 677.88K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $24.30M, representing 2.57% of its reported portfolio and ranking #12.
Has Claret Asset Management Corp been buying or selling INDV?
In the latest 13F filing (Q3 2026), Claret Asset Management Corp reduced its position in INDV. The position peaked in Q2 2026 at 685.52K shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, Two Seas Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.